샘플 요청 목록

 카트 문의
시장보고서
상품코드
1577508

세계의 심장 발작 진단 시장

Heart Attack Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심장 발작 진단 세계 시장은 2030년까지 198억 달러에 달할 것으로 전망

2023년 137억 달러로 추정되는 세계 심장 발작 진단 시장은 2023-2030년 동안 연평균 5.5% 성장하여 2030년에는 198억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 병원 최종사용 부문은 CAGR 6.1%를 기록하여 분석 기간 종료 시점에 98억 달러에 도달할 것으로 예상됩니다. 진단 센터 및 최종 사용 분야는 분석 기간 동안 CAGR 5.1%의 성장률을 기록할 것으로 예상됩니다.

미국 시장 37억 달러, 중국은 CAGR 9.0%로 성장 전망

미국의 심장 발작 진단 시장은 2023년 37억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 시장 규모가 42억 달러에 달할 것으로 예상되며, 2023-2030년 분석 기간 동안 9.0%의 CAGR을 기록할 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.2%와 5.6%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.4%의 성장률을 보일 것으로 예상됩니다.

세계 심장 발작 진단 시장 - 주요 동향 및 촉진요인 요약

심장 발작 진단이 심혈관 치료의 판도를 바꿀 수 있는 이유는 무엇일까?

심근경색 진단은 환자의 예후를 크게 좌우하는 심근경색(MI)을 조기에 정확하게 감지할 수 있는 중요한 도구를 제공하며, 현대 심혈관 치료의 핵심이 되고 있습니다. 하지만 이러한 진단이 이처럼 큰 영향을 미치는 이유는 무엇이며, 의료 분야에서 그 역할이 점점 더 중요해지고 있는 이유는 무엇일까? 심장마비는 막힘으로 인해 심장으로의 혈류가 제한되어 조직 손상을 일으켜 발생합니다. 혈전용해 요법이나 경피적 관상동맥 중재술(PCI)과 같은 생명을 구하는 치료의 효과는 조기 발견에 달려 있기 때문에 적시에 진단하는 것이 매우 중요합니다. '골든타임'(증상 발생 직후의 중요한 시간대)이라는 개념에 따라 임상의가 치료 결정을 내릴 수 있는 신속하고 신뢰할 수 있는 진단 도구가 필수적입니다. 현재의 진단 접근법은 심전도(ECG), 심장 바이오마커 검사, 영상 진단 기술을 결합하여 심장 질환의 유무와 심각성을 파악하는 것입니다. 이러한 도구의 속도와 정확성은 환자가 제때 적절한 치료를 받을 수 있는지 여부를 결정하는 핵심 요소이기 때문에 심장 발작 진단의 지속적인 혁신의 필요성이 강조되고 있습니다. 이러한 지속적인 발전은 생존율을 향상시킬 뿐만 아니라 장기적인 합병증을 최소화할 수 있기 때문에 이러한 기술은 응급실과 일상 진료 모두에 필수적인 요소입니다.

심장 발작 진단 시장을 형성하고 있는 새로운 트렌드는?

심장 발작 진단 시장은 환자 예후 개선을 목표로 한 최첨단 혁신과 임상 관행의 변화로 인해 변화의 시기를 맞이하고 있습니다. 가장 중요한 발전 중 하나는 고감도 심근 트로포닌(hs-cTn) 분석법의 채택이 확대되고 있다는 점입니다. 이러한 민감도 향상으로 심장마비를 더 일찍, 더 정확하게 발견할 수 있게 되어, 특히 비정형적인 증상을 가진 환자에서 치료 시간을 단축하고 예후 예측 정확도를 향상시킬 수 있습니다. 또 다른 큰 트렌드는 POCT(Point-of-Care Test) 기기의 보급으로, 침대 옆이나 구급차와 같은 병원 전 환경에서도 신속한 진단을 가능하게 합니다. 이러한 휴대용 기기는 몇 분 안에 결과를 제공함으로써 보다 신속한 분류를 지원하고, 중앙 검사실 검사에 대한 의존도를 낮춰 응급의료에 변화를 가져오고 있습니다. 또한 진단 플랫폼에 인공지능(AI)과 머신러닝을 통합해 심전도 패턴, 영상 진단 결과 등 복잡한 데이터 해석에 혁명을 일으켜 인간 임상의가 간과할 수 있는 미묘한 징후를 조기에 발견할 수 있도록 돕고 있습니다. 또한, 나트륨 이뇨 펩타이드, 염증 마커 등 여러 바이오마커를 조합한 멀티마커 패널은 심장 건강 상태를 더 미묘하게 파악하여 심장 발작과 다른 심장 질환을 감별하는 데 도움이 될 수 있다는 점에서 주목을 받고 있습니다. 이러한 추세들을 종합하면, 심장 발작 진단은 더 빠르고, 더 정확하고, 점점 더 개인화되고 있으며, 이는 심혈관 치료에서 정밀 의료로의 전환을 반영하고 있습니다.

새로운 기술은 심장 발작 진단을 어떻게 재정의하고 있을까?

기술의 비약적인 발전은 심장 발작 진단의 상황을 재편하고 있으며, 그 어느 때보다 효율적이고 접근성이 높으며 정확한 진단 도구가 등장하고 있습니다. 가장 영향력 있는 발전 중 하나는 진단 기기의 소형화로, 원격지나 자원이 제한된 환경에서도 환자 곁에서 신속하게 검사 결과를 제공할 수 있는 휴대용 핸드헬드 시스템이 탄생했습니다. POC(Point-of-Care) 심장 바이오마커 분석기, 휴대용 심전도 모니터 등 이러한 기기들은 복잡한 검사실 환경 없이도 즉각적인 진단과 치료 방침을 결정할 수 있도록함으로써 응급의료에 변화를 가져오고 있습니다. 웨어러블 기술은 이 분야의 또 다른 혁신으로, 스마트워치와 헬스밴드는 현재 심장 활동을 지속적으로 모니터링하고 사용자나 의료진에게 심장마비 가능성을 실시간으로 경고하는 기능을 갖추고 있습니다. 이 기능은 잠재적인 심장 질환에 대한 사전 예방적 관리와 신속한 대응을 가능케 하기 때문에 고위험군 환자에게 특히 유용합니다. 또한, 인공지능(AI)은 복잡한 심장 데이터를 빠르고 정확하게 해석할 수 있게함으로써 심초음파, CT 스캔, MRI와 같은 영상 진단의 능력을 향상시키고 있으며, AI 기반 플랫폼은 사람의 눈으로는 놓칠 수 있는 미묘한 패턴과 이상 징후를 감지할 수 있어 보다 빠르고 정확한 진단을 가능하게 합니다. 보다 빠르고 정확한 진단을 가능하게 합니다. 또한 클라우드 기반 플랫폼과 원격의료 통합을 통해 원격 진단이 가능해져 임상의가 거의 모든 곳에서 검사 결과에 쉽게 접근하고 해석할 수 있게 되었습니다. 이러한 기술 혁신은 심장 발작 진단의 정확성과 접근성을 향상시킬 뿐만 아니라 심혈관 치료 제공 방식에 혁명을 일으켜 환자 관리에 대한 보다 적극적이고 데이터 중심적인 접근 방식을 위한 길을 열어주고 있습니다.

심장 발작 진단 시장의 급격한 성장의 주요 촉진요인은?

심장 발작 진단 시장의 성장은 주로 기술 발전, 심혈관질환의 부담 증가, 빠르고 접근하기 쉬운 진단 솔루션으로의 전환 등 다양한 요인에 의해 촉진되고 있습니다. 주요 성장 요인 중 하나는 전 세계적으로 심혈관질환의 증가이며, 심혈관질환은 여전히 전 세계 사망 원인 중 하나입니다. 인구 고령화와 비만, 고혈압, 당뇨병과 같은 생활습관 관련 위험요인의 유병률 증가로 인해 신뢰할 수 있는 진단 도구가 필요한 환자층이 크게 확대되고 있습니다. 또한 조기 발견과 예방의 중요성에 대한 인식이 높아지면서 심장마비를 조기에 발견할 수 있는 첨단 바이오마커 분석 및 비침습적 영상 기술에 대한 수요가 증가하고 있습니다. 또 다른 주요 촉진요인은 응급실, 외래 진료소, 심지어 재택 의료 환경에서도 신속한 진단 기능을 제공하는 POC(Point-of-Care)(POCT) 기기의 채택이 확대되고 있다는 점입니다. 이러한 휴대용 기기는 신속한 진단 및 치료 시작에 대한 요구를 충족시켜 병원 검사실의 부담을 줄이고 바쁜 응급실에서 환자 처리 능력을 향상시키며, AI 기반 진단 플랫폼과 고감도 바이오마커 검사 등의 혁신은 진단 정확도 향상과 개인화된 위험 평가의 실현으로 시장 성장을 더욱 촉진할 것으로 보입니다. 시장의 성장을 더욱 촉진하고 있습니다. 또한, 원격의료 및 원격 모니터링 솔루션의 사용이 증가함에 따라, 특히 전통적인 의료 시설에 대한 접근성이 제한적인 농촌 지역이나 의료 서비스가 부족한 지역에서 심장 발작 진단의 활용 범위가 확대되고 있습니다. 유리한 규제 프레임워크와 상환 정책도 새로운 진단 기술의 개발 및 채택을 촉진하고 더 많은 환자들에게 접근을 가능하게 하고 있습니다. 이러한 요인들이 조사개발에 대한 지속적인 투자와 결합하여 시장 상황을 발전시키고 있으며, 심장 발작 진단은 진화하는 순환기 치료의 중요한 구성요소로 자리매김하고 있습니다.

조사 대상 기업 사례(총 35개 주목)

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.10.29

Global Heart Attack Diagnostics Market to Reach US$19.8 Billion by 2030

The global market for Heart Attack Diagnostics estimated at US$13.7 Billion in the year 2023, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 9.0% CAGR

The Heart Attack Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Heart Attack Diagnostics Market - Key Trends and Drivers Summarized

Why Are Heart Attack Diagnostics a Game-Changer in Cardiovascular Care?

Heart attack diagnostics have become a cornerstone of modern cardiovascular care, offering critical tools for the early and precise detection of myocardial infarction (MI), which can significantly alter patient outcomes. But what exactly makes these diagnostics so impactful, and why is their role in healthcare becoming increasingly indispensable? Heart attacks occur when a blockage restricts blood flow to the heart, causing tissue damage that, if not treated promptly, can lead to irreversible damage or death. Timely diagnosis is crucial because the effectiveness of life-saving interventions like thrombolysis and percutaneous coronary intervention (PCI) hinges on early detection. The concept of the “golden hour”—the critical time window immediately following the onset of symptoms—makes it imperative that clinicians have access to reliable and rapid diagnostic tools to guide treatment decisions. Current diagnostic approaches rely on a combination of electrocardiograms (ECGs), cardiac biomarker testing, and imaging techniques to identify the presence and severity of heart damage. The speed and accuracy of these tools are key in determining whether a patient receives appropriate care in time, highlighting the need for continuous innovation in heart attack diagnostics. This ongoing evolution not only improves survival rates but also minimizes long-term complications, making these technologies vital for both emergency and routine clinical practice.

Which Emerging Trends Are Shaping the Heart Attack Diagnostics Market?

The heart attack diagnostics market is undergoing a transformative phase, driven by cutting-edge innovations and shifts in clinical practices aimed at improving patient outcomes. One of the most significant developments is the growing adoption of high-sensitivity cardiac troponin (hs-cTn) assays, which can detect extremely low levels of troponin, a key biomarker for myocardial injury. This enhanced sensitivity allows for earlier and more accurate detection of heart attacks, reducing time-to-treatment and improving prognostic accuracy, especially in patients with atypical symptoms. Another major trend is the proliferation of point-of-care testing (POCT) devices, which enable rapid diagnosis at the bedside or even in pre-hospital settings such as ambulances. These portable devices are transforming emergency care by providing results in minutes, thereby supporting quicker triage and reducing reliance on centralized laboratory testing. In addition, the integration of artificial intelligence (AI) and machine learning in diagnostic platforms is revolutionizing the interpretation of complex data, such as ECG patterns and imaging results, leading to earlier detection of subtle signs that might be overlooked by human clinicians. Moreover, multi-marker panels that combine several biomarkers—such as natriuretic peptides and inflammatory markers—are gaining attention, as they offer a more nuanced view of cardiac health and help differentiate heart attacks from other cardiac conditions. Collectively, these trends are making heart attack diagnostics faster, more accurate, and increasingly personalized, reflecting a shift towards precision medicine in cardiovascular care.

How Are New Technologies Redefining Heart Attack Diagnostics?

Technological breakthroughs are reshaping the heart attack diagnostics landscape, making tools more efficient, accessible, and accurate than ever before. One of the most impactful advancements is the miniaturization of diagnostic devices, which has led to the creation of portable and handheld systems that can deliver rapid test results at the patient’s side, even in remote or resource-limited settings. These devices, which include point-of-care cardiac biomarker analyzers and portable ECG monitors, are transforming emergency care by enabling immediate diagnosis and treatment decisions without the need for complex laboratory setups. Wearable technologies are another game-changer in this space, with smartwatches and health bands now equipped to monitor cardiac activity continuously, alerting users and healthcare providers to potential heart attack symptoms in real time. This capability is particularly valuable for high-risk patients, as it allows for proactive management and faster response to potential cardiac events. Additionally, artificial intelligence (AI) is enhancing the capabilities of diagnostic imaging, such as echocardiograms, CT scans, and MRIs, by enabling rapid and more precise interpretation of complex cardiac data. AI-driven platforms can detect subtle patterns and anomalies that might be missed by human eyes, leading to earlier and more confident diagnoses. Furthermore, cloud-based platforms and telehealth integration are enabling remote diagnostics, making it easier for clinicians to access and interpret test results from virtually anywhere. These technological innovations are not only improving the accuracy and accessibility of heart attack diagnostics but are also revolutionizing the way cardiovascular care is delivered, paving the way for a more proactive, data-driven approach to patient management.

What Are the Key Drivers Behind the Rapid Growth of the Heart Attack Diagnostics Market?

The growth in the heart attack diagnostics market is driven by a variety of factors, primarily fueled by advancements in technology, an increasing burden of cardiovascular diseases, and a shift towards rapid and accessible diagnostic solutions. One of the main growth drivers is the global rise in cardiovascular diseases, which remain the leading cause of death worldwide. The aging population, coupled with the increasing prevalence of lifestyle-related risk factors such as obesity, hypertension, and diabetes, is significantly expanding the patient pool in need of reliable diagnostic tools. Moreover, the heightened awareness of the importance of early detection and prevention is boosting demand for advanced biomarker assays and non-invasive imaging technologies that can identify heart attacks in their earliest stages. Another key driver is the growing adoption of point-of-care testing (POCT) devices, which provide rapid diagnostic capabilities in emergency settings, outpatient clinics, and even home care environments. These portable devices are meeting the need for quicker diagnosis and treatment initiation, reducing the strain on hospital laboratories and improving patient throughput in busy emergency departments. Technological innovations, such as AI-enhanced diagnostic platforms and high-sensitivity biomarker tests, are further propelling market growth by offering improved diagnostic accuracy and enabling personalized risk assessment. Additionally, the rising use of telehealth and remote monitoring solutions is expanding the reach of heart attack diagnostics, particularly in rural and underserved areas where access to traditional healthcare facilities is limited. Favorable regulatory frameworks and reimbursement policies are also encouraging the development and adoption of new diagnostic technologies, making them more accessible to a broader patient base. These factors, combined with ongoing investment in research and development, are driving the heart attack diagnostics market forward, establishing it as a key component in the evolving landscape of cardiovascular care.

Select Competitors (Total 35 Featured) -

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Attack Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Drives Demand for Heart Attack Diagnostic Solutions
    • Here's the Story: How Growing Awareness of Early Detection Expands the Addressable Market for Heart Attack Diagnostics
    • Increasing Adoption of Point-of-Care Testing Propels Market Growth for Rapid Diagnostic Tools
    • Advancements in Biomarker Identification Strengthen Business Case for High-Sensitivity Cardiac Tests
    • Here's How the Shift Towards Personalized Medicine Generates Opportunities for Advanced Cardiac Diagnostic Platforms
    • Rising Focus on Minimally Invasive Testing Boosts Market Potential for Non-Invasive Imaging Technologies
    • Expansion of Telemedicine and Remote Monitoring Transforms Market Dynamics for Heart Attack Diagnostics
    • Emphasis on Reducing Diagnosis Time in Emergency Settings Sustains Demand for Quick and Accurate Testing Methods
    • Here's How Growing Investments in AI and Machine Learning Drive Innovation in Predictive Cardiac Diagnostic Tools
    • Increasing Use of Wearable Health Devices Enhances Market Scope for Continuous Heart Health Monitoring
    • Emergence of At-Home Testing Kits Unlocks New Market Potential in Consumer-Driven Cardiac Health Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Attack Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제